Gilead Sciences Inc annual gross profit for fiscal TTM was $23.6 billion, an increase of 1.7% from $23.2 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | $23.6B | $23.2B | $22.5B | $27.1B | $21.6B | $20.7B | $20.1B | $17.8B | $17.3B | $21.7B | $26.1B | $28.6B | $21.1B | $8.3B | $7.2B | $6.3B | $6.1B | $5.4B | $4.2B | $3.5B | $2.6B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | $5.5B | $6.3B | $6.2B | $5.6B | $5.1B | $6.0B | $6.0B | $5.4B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GILD metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All GILD financial statements → Interactive GILD charts →
About TickerBase · Data methodology & sources